Literature DB >> 2999796

Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis.

P Cresswell.   

Abstract

Newly synthesized class II HLA antigens being transported to the surface of human B-lymphoblastoid cell lines (B-LCL) interact with transferrin-neuraminidase conjugates internalized by means of receptor-mediated endocytosis. Class II antigens, isolated from [35S]methionine-labeled B-LCL after incubation with the conjugates at 37 degrees C, showed extensive desialylation of associated invariant chain and detectable loss of beta-subunit sialic acid on analysis by two-dimensional gel electrophoresis. An equal amount of unconjugated neuraminidase had no effect, and desialylation of class II antigen components was blocked when access of transferrin-neuraminidase conjugates to the B-LCL transferrin receptors was competitively inhibited by the addition of excess iron-saturated transferrin. The conjugates were shown to cycle through the cells in the same way as unconjugated transferrin, being first internalized and then rapidly secreted in an undegraded form. The data suggest that the exocytic pathway taken by class II antigens intersects the route followed by recycling transferrin receptors and that the interaction occurs prior to the dissociation of the invariant chain from the class II antigen complex. Similar intracellular interactions between class II molecules and foreign proteins internalized by antigen-presenting cells may be important in class II antigen-restricted recognition by helper T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999796      PMCID: PMC391468          DOI: 10.1073/pnas.82.23.8188

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  Transferrin receptors on human B and T lymphoblastoid cell lines.

Authors:  J W Larrick; P Cresswell
Journal:  Biochim Biophys Acta       Date:  1979-04-03

3.  Detection of a common polypeptide chain in I--A and I--E sub-region immunoprecipitates.

Authors:  P P Jones; D B Murphy; D Hewgill; H O McDevitt
Journal:  Mol Immunol       Date:  1979-01       Impact factor: 4.407

4.  Analysis of HLA-D region-associated molecules with monoclonal antibody.

Authors:  D J Charron; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The receptosome: an intermediate organelle of receptor mediated endocytosis in cultured fibroblasts.

Authors:  M C Willingham; I Pastan
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

7.  Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocarcinoma stem cells.

Authors:  M Karin; B Mintz
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

8.  Transferrin uptake by cultured rat embryo fibroblasts. The influence of temperature and incubation time, subcellular distribution and short-term kinetic studies.

Authors:  J N Octave; Y J Schneider; R R Crichton; A Trouet
Journal:  Eur J Biochem       Date:  1981-04

9.  Coated pits, coated vesicles, and receptor-mediated endocytosis.

Authors:  J L Goldstein; R G Anderson; M S Brown
Journal:  Nature       Date:  1979-06-21       Impact factor: 49.962

10.  Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.

Authors:  J Carlsson; H Drevin; R Axén
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

View more
  49 in total

1.  Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.

Authors:  V Brachet; G Péhau-Arnaudet; C Desaymard; G Raposo; S Amigorena
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.

Authors:  G Moldenhauer; C Henne; J Karhausen; P Möller
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

3.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

Authors:  P A Roche; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

Review 4.  Transport and expression of HLA class-II glycoproteins.

Authors:  P Cresswell; J S Blum; J E Davis; M S Marks
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

5.  Localization of MHC class II molecules in murine bone marrow-derived macrophages.

Authors:  T Lang; J C Antoine
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

6.  The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides "in vivo".

Authors:  M Viguier; K Dornmair; B R Clark; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 7.  The cellular immune response to nucleocapsid antigens in hepatitis B virus infection.

Authors:  M U Mondelli; F V Chisari; C Ferrari
Journal:  Springer Semin Immunopathol       Date:  1990

8.  Regulation of intestinal non-haem iron absorption.

Authors:  M Lombard; E Chua; P O'Toole
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

9.  Distribution of class II major histocompatibility antigens in enterocytes of the rat jejunum and their association with organelles of the endocytic pathway.

Authors:  G Mayrhofer; L D Spargo
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

Review 10.  Recognition of influenza virus proteins by cytotoxic T lymphocytes.

Authors:  A R Townsend
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.